Beta Bionics reported Q4 2025 sales growth, but analysts raised concerns about valuation and slower patient starts.

Shares of Beta Bionics fell after the maker of insulin-delivery systems shared preliminary data for new patient starts that were below expectations. The stock slipped 36%, to $20.5, on Friday. Over ...

Procter & Gamble (PG) looks like a strong buy at a multi-year valuation low—see growth, buybacks, inflation/trade risks, and ...

A big reason Burry thinks a crash this time around could be worse is because of the growing popularity of passive investing.

Institutions are applying Bitcoin options strategies to XRP, SOL, and ETH, and they are transforming altcoins into ...

Beta Glass Plc delivered a decisive earnings breakout in 2025, emerging as one of the Nigerian Exchange’s strongest-performing industrial stocks. The share ...

Beta Bionics reported that its installed customer base reached at least 35,000 users, up 128% compared to the fourth quarter of 2024. The company’s Durable Medical Equipment channel generated at least ...

Only 65 percent of the 4,810 farm-to-market road (FMR) projects under the Department of Public Works and Highways (DPWH) were ...

Welcome to the BPCL Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent ...

Another top ETF for retirees is the Vanguard Value Index Fund ETF. It yields a solid 2% and has minimal fees, with its ...

The Nigerian stock market ended the week bullish, with sustained buying in mid- and large-cap stocks lifting indices and ...

Overview: Bitcoin’s push toward $94,000 reflects strong institutional ETF demand and growing confidence that regulatory ...